|
FMNL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.2471000000458E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.11289999952191E-07 |
| Normal-vs-Stage2 |
6.050600E-01 |
| Normal-vs-Stage3 |
3.220000E-04 |
| Normal-vs-Stage4 |
4.586400E-04 |
| Stage1-vs-Stage2 |
4.646000E-04 |
| Stage1-vs-Stage3 |
8.864800E-01 |
| Stage1-vs-Stage4 |
8.256400E-01 |
| Stage2-vs-Stage3 |
3.437400E-03 |
| Stage2-vs-Stage4 |
2.783200E-03 |
| Stage3-vs-Stage4 |
7.675400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.32770000011485E-07 |
| Normal-vs-AfricanAmerican |
6.295900E-03 |
| Normal-vs-Asian |
3.744800E-03 |
| Caucasian-vs-AfricanAmerican |
6.860000E-01 |
| Caucasian-vs-Asian |
7.632600E-01 |
| AfricanAmerican-vs-Asian |
8.831600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.602600E-03 |
| Normal-vs-Female |
5.02160000026564E-07 |
| Male-vs-Female |
1.478400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.46989999955305E-07 |
| Normal-vs-Age(41-60Yrs) |
1.93619999999672E-05 |
| Normal-vs-Age(61-80Yrs) |
3.338800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.832600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.970600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.139030E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.596200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.460500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.984200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.904600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.470390E-02 |
| Classical-VS-Follicular |
1.017830E-04 |
| Classical-VS-Other |
7.899800E-01 |
| Classical-VS-Normal |
3.34719999495192E-08 |
| Tall-VS-Follicular |
4.02470000000488E-05 |
| Tall-VS-Other |
1.969580E-01 |
| Tall-VS-Normal |
4.81720000000685E-06 |
| Follicular-VS-Other |
3.039400E-01 |
| Follicular-VS-Normal |
9.234800E-01 |
| Other-VS-Normal |
2.785400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.780160E-02 |
| Normal-vs-N1 |
3.64720000001206E-06 |
| N0-vs-N1 |
7.189600E-04 |
|
|
